LONDON (AP) — The pharmaceutical giant GlaxoSmithKline says it has rejected an unsolicited 50 billion-pound ($68.4 billion) bid from Unilever for its consumer healthcare goods unit. The unit is a joint venture in a partnership with Pfizer, which holds a minority interest. GSK said Saturday that it rejected three bids from Unilever last year – the latest in December — because they undervalued the unit. Both companies confirmed the offer following a report in Britain’s Sunday Times. Unilever said there can be no certainty any agreement will be reached. GSK’s brands include the painkiller Advil and Sensodyne toothpaste. Unilever’s wide assortment of consumer products include the Hellmann’s Dove brands.
BE PART OF THE CONVERSATION
ABC 17 News is committed to providing a forum for civil and constructive conversation.
Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here
If you would like to share a story idea, please submit it here.